Abstract
Wastewater toxicity is often assessed through limited sampling, which may not capture endpoint-specific variability or year-round treatment performance. In this study, influent, secondary effluent and final effluent samples were collected monthly over 12 consecutive months from a full-scale municipal wastewater treatment plant. Five complementary toxicity endpoints, including cytotoxicity, acute toxicity, genotoxicity, neurotoxicity and estrogenic activity, were evaluated using a battery of bioassays. Measurable responses were observed for all five endpoints across the treatment stages. All endpoints decreased during treatment, with estrogenic activity showing the highest whole-process removal (96.5%), whereas removal of the other four endpoints ranged from 47.9% to 65.0%. Secondary treatment accounted for 88.6–102.0% of the corresponding whole-process reductions, whereas tertiary treatment provided little additional removal of acute toxicity and neurotoxicity. Despite substantial removal, residual risks associated with acute toxicity, neurotoxicity and estrogenic activity remained in the final effluent. Genotoxicity exhibited the greatest monthly variability and was significantly higher in summer in the influent and secondary effluent, whereas the other four endpoints displayed no significant seasonal differences. Similarly, no significant seasonal differences were detected in total removal for any endpoint. Associations of toxicity levels and removal efficiencies with TOC and nitrogen parameters were generally limited, indicating that conventional water-quality parameters did not reliably track changes in biological effects. These findings indicate that the temporal representativeness of toxicity assessment varies among endpoints and highlight the value of repeated multi-endpoint assessment as a complement to conventional wastewater monitoring.